Covid 19 (Coronavirus Disease 2019) merupakan penyakit menular yang disebabkan oleh virus SARS-Cov-V2 (Severe acute respiratory syndrome coronavirus 2). Pertama kali di identifikasi di kota Wuhan, Tiongkok pada Desember 2019.

Coronavirus merupakan istilah bagi sekelompok virus dari subfamily Coronavirinae dari keluarga Coronaviridae yang merupakan turunan ordo Nidovirales. Kelompok virus ini dapat menyebabkan penyakit pada hewan maupun manusia (Zoonosis). Nama Corona merupakan bahasa latin yang berarti mahkota, bentuk virus yang mirip matahari yang mempunyai mahkota di sekelilingnya.

Organisasi Kesehatan Dunia (WHO) telah mengumumkan nama Covid 19 sebagai nama resmi untuk penyakit ini. Covid 19 merupakan singkatan dari “co” untuk Corona, “vi” untuk virus, “d” untuk disease, dan “19” merupakan tahun pertama kali muncul.

Gejala Covid 19

Gejala yang timbul dapat beragam dari bersifat asimtomatik atau tanpa merasakan gejala apapun, gejala ringan, sedang dan berat. Secara umum gejala yang timbul dapat berupa:

  1. Demam
  2. Batuk kering
  3. Pilek
  4. Nyeri tenggorokan
  5. Nyeri kepala
  6. Sesak nafas
  7. Diare
  8. Hilangnya indera perasa dan penciuman
  9. Keletihan

Gejala tersebut nampak sakit ringan biasa yang bagi kebanyakan orang akan dibiarkan tanpa dilakukan pengobatan, ataupun diobati dengan dengan obat flu biasa.

Sesak nafas, akan menjadi gejala lanjutan yang menyebabkan penderita harus dibawa ke Rumah Sakit, dengan adanya sesak nafas maka penderita sudah masuk ke tahap lanjut sakit corona.

Diagnosis pneumonia merupakan manifestasi dari corona, yang dapat berkembang menjadi gagal nafas dan membutuhkan alat bantu ventilator. Masa inkubasi oleh WHO diperkirakan 1-14 hari. Selama masa inkubasi penderita tidak akan merasakan gejala apapun.

Patogenesis Covid 19

Terdapat 7 jenis virus corona yang dapat menular ke manusia, yaitu; dua alphacoronavirus (229E dan NL63) dan empat betacoronavirus, yakni OC43, HKU1, Middle respiratory syndrome-associated coronavirus (MERS-CoV), dan severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Yang ketujuh adalah Coronavirus tipe baru yang menjadi penyebab kejadian luar biasa di Wuhan, yakni Novel Coronavirus 2019 (2019-nCoV). Isolat 229E dan OC43 ditemukan sekitar 50 tahun yang lalu. NL63 dan HKU1 diidentifikasi mengikuti kejadian luar biasa SARS.

Struktur dan replikasi virus corona
Struktur dan replikasi virus corona, sumber: DOI:10.1016/j.drudis.2020.01.015

SARS CoV-2 merupakan keluarga beta-coronavirus, secara genom mirip dengan SARS CoV-1 (SARS) 70% dan MERS Cov (MERS) 50%. Dengan rute transmisi melalui saluran pernafasan baik secara langsung maupun tidak langsung. SARS CoV-2 mampu bertahan dari sistem pertahanan tubuh dan mereplikasi diri di saluran nafas kemudian akan merusak saluran pernapasan bagian bawah, jantung, ginjal, saluran pencernaan serta pembuluh darah distal.

Tanda laboratorium yang dapat diamati adalah penurunan limfosit dan meningkatnya neutrofil secara signifikan, penurunan sel T, CD⁴ CD⁸ serta peningkatan CRP. Pada SARS CoV-2 ini juga terjadi peningkatan koagulasi, peningkatan waktu protombin, peningkatan D dimer dan fibrinogen, yang dapat berkembang menjadi disseminated intravascular coagulation (DIC) (Cao, 2020)

Diagnosis

Uji PCR (polymerase chain reaction) merupakan uji virus paling akurat. Jika sample yang diperiksa di ditemukan adanya virus corona walaupun dalam jumlah sedikit dan walaupun penderita masih dalam tahap inkubasi. Dengan begitu penanganan akan lebih tepat.

Kekurangan metode PCR adalah membutuhkan waktu relatif lama sekitar 3 hari. Sehingga WHO juga merekomendasikan alat uji yang lebih cepat seperti rapid (antibodi) test dan swab antigen yang hanya membutuhkan waktu beberapa menit saja, walaupun secara hasil keakuratan masih jauh dibanding metode PCR.

Varian Coronavirus

NoKodeNama VarianAsalKeterangan
1B. 1.1.7AlphaInggrisSeptember 2020
2B.1.351BetaAfrika SelatanSeptember 2020
3P.1GammaBrazilOktober 2020
4B.1.617.2DeltaB. 1.1.7IndiaOktober 2020
5B.1.427/B.1.429EpsilonAmerika SerikatMaret 2020
6P.2ZetaBrazil
7B.1.525EtaBanyak negaraOktober 2020
8P.3ThetaFilipinaJanuari 2021
9B.1.526IotaNY, Amerika SerikatJanuari 2021
10B.1.617.1KappaIndiaDesember 2020
11Delta AY 4.2Inggris
12B.1.1.529OmicronAfrika SelatanNovember 2021
13Gabungan Omicron subvarian BA.2.10.1 dan BA.275Omicron subvarian XBB2022
Varian Coronavirus yang menjadi perhatian WHO

Penularan

Virus corona dapat menular dari manusia ke manusia melalui kontak langsung dalam jarak dekat dengan cara:

  1. Droplet
  2. Sentuhan
  3. Aerosol (terjadi pada tempat tempat tertentu)

Pencegahan

Yang paling berbahaya dari virus ini adalah tingkat penyebarannya yang sangat tinggi, diketahui dari awal muncul virus ini di akhir Desember 2019 sampai saat ini penderita Covid 19 telah mencapai [covid-watch status=”confirmed”] juta jiwa di seluruh dunia, sedangkan di Indonesia sejak kasus pertama di identifikasi 2 maret 2020 sampai hari ini telah mencapai [covid-watch country=”Indonesia” status=”confirmed”]  jiwa.

Untuk mencegah penyebaran Covid 19 setiap orang perlu:

  1. Mencuci tangan sesering mungkin dengan sabun antiseptik
  2. Menjaga jarak (social distancing) minimal 1 meter agar saat seseorang bersin atau batuk tidak ada orang di sekitarnya yang mengirup droplets.
  3. Menghindari menyentuh mata, hidung dan mulut. Tangang yang tidak bersih dan mungkin terdapat virus akan dapat mengantarkan virus tersebut masuk ke tubuh melalui mata, hidung dan mulut.
  4. Menjaga hidup sehat dan selalu mematuhi instruksi dari pemerintah dan petugas kesehatan.

Komplikasi Covid 19: D-Dimer sebagai Indikator

Korelasi tingkat D Dimer dengan keparahan pasien covid 19
Korelasi kadar D-Dimer dengan tingkat keparahan , sumber : Doi:10.1001/jama.2020.1585

Peningkatan D-Dimer menjadi parameter utama terjadinya hiperkoagulasi. Kadar D-dimer akan meningkat sampai hari ke tujuh dan bertahan pada angka yang cukup tinggi. Pada pasien Covid 19 kritis ditemukan kadar D-Dimer nya lebih tinggi daripada pasien dengan gejala ringan (Zhang et al., 2020). Serta ada korelasi antara tingkat kematian dan kadar D-dimer yang tinggi (Wang et al., 2020).

Pada pasien Covid 19 yang mengalami emboli paru dan Trombosis vena dalam (DVT), D-Dimer dapat menjadi indikator pemantauan DVT dan emboli paru.

Shah et al., 2020

Komplikasi yang sering terjadi pada pasien Covid 19 adalah:

  1. ARDS
  2. Aritmia
  3. Syok
  4. Gagal jantung akut

Acute Respiratory Distress Syndrome Pada Covid 19

Pada awal infeksi memang memiliki gejala yang ringan, beberapa orang bahkan tidak mengalami gejala sama sekali. Covid 19 memiliki keunggulan dalam hal penyebaran dan mutasi. Ketika virus corona sudah memenangkan pertempuran melawan sistem kekebalan tubuh, selanjutnya berkembang dengan cepat merusak organ vital. Menjadikan paru – paru sebagai pusat penyebaran dan secara cepat merusak sistem darah, enzim, dan metabolisme.

Timbulnya Acute respiratory distress syndrome (ARDS) adalah sekuel terburuk yang tidak pernah dinantikan. Di lapangan, ARDS Covid 19 dan ARDS non Covid 19 memiliki perbedaan yang membingungkan petugas kesehatan, berbeda jauh dengan ilmu yang telah di pelajari. Petugas kesehatan telah bertahun- tahun melihat pasien ARDS dengan kondisi penurunan kesadaran, namun berubah seketika saat pandemi Covid 19 sebagian besar pasien mengalami ARDS hipoksemi dengan kesadaran compos mentis.

Vaksin, Antivirus dan terapi tambahan COVID 19

Banyak negara telah melakukan penelitian untuk mengembangkan vaksin Covid 19 terutama negara Tiongkok, Australia dan Amerika Serikat, namun para ahli menyatakan vaksin Covid 19 baru dapat tersedia paling cepat tahun 2021.

Pengembangan Vaksin

NIH (National Institutes of Health) Amerika, telah bertahun-tahun meneliti berbagai jenis penyakit, virus dan jenis pengobatan nya. Termasuk coronavirus yang telah diteliti dan pengembangan vaksinnya.

NIH mengembangkan vaksin coronavirus yang bersifat universal karena dikemudian hari tidak diketahui virus corona mana yang akan menjadi pandemi, termasuk seperti Covid 19 seperti saat ini. Di 16 Maret 2020 NIH bekerjasama dengan perusahaan Moderna telah memasuki uji klinis pertama untuk vaksin mRNA 1273.

Penjelasan cara kerja vaksin mRNA dari channel
Alila Medical Media

Vaksin tipe messenger RNA (mRNA) banyak dikembangkan oleh berbagai perusahaan farmasi, moderna dan Pfizer/ BioNTech adalah diantara perusahaan tersebut. Cara kerja mRNA adalah dengan membuat protein lonjakan SARS Cov-2 dalam tubuh yang telah disuntikkan vaksin. Protein lonjakan kemudian muncul dipermukaan makrofag dan memicu respon kekebalan seperti kekebalan alami saat terinfeksi SARS Cov-2. Berbeda dengan vaksin konvensional yang didalamnya mengandung patogen atau bagian dari patogen penyakit. messenger RNA adalah vaksin generasi baru, protein buatan yang di dalamnya terdapat messenger RNA yang dikode seperti bagian dari patogen SARS Cov-2.

Setelah di suntikkan, vaksin akan membuat molekul antigen dari patogen Sars-Cov-2, setelah protein kekebalan terbentuk maka dengan segera mRNA didegradasi dari tubuh oleh enzim. Sedangkan protein kekebalan tidak akan terdegradasi karena terlindung oleh nanopartikel lipid yang menyamarkannya dari sistem kekebalan tubuh manusia. Protein kekebalan ini akan segera dengan cepat beradaptasi dan bermutasi ketika patogen asli SARS Cov-2 menginfeksi kedalam tubuh.

Obat Antivirus yang saat ini digunakan

Selain pengembangan vaksin, para ahli juga tengah meneliti penggunaan antivirus yang mungkin dapat digunakan pada pasien Covid 19 seperti antivirus remdesivir (pernah digunakan saat wabah Mers), lopinavir/ ritonavir (biasa digunakan pada HIV/AIDS), dan interferon beta (biasa digunakan pada penyakit Hepatitis C dan B), penggunaan obat Tamiflu dan Avigan yang sebelumnya digunakan pada kasus Flu burung.

Molnupiravir dan paxlovid tablet digunakan untuk pengobatan pasien covid 19 gejala ringan. Obat ini efektif menurunkan resiko rawat inap dan kematian.

Program Vaksinasi Pemerintah

Pemerintah akan menjalankan program vaksinasi gratis untuk seluruh warga dengan vaksin yang berasal dari berbagai produsen vaksin seperti PT Biofarma, AstraZeneca, Sinopharm, Moderna, Pfizer-BioNtech, dan Sinovac Biotech. Vaksin Merah Putih atau vaksin anak bangsa sendiri yang di kembangkan oleh Eickjman, serta Universitas Airlangga Surabaya akan diserahkan ke PT Biofarma untuk produksi masal.

Terapi Plasma Konvalesent

Prinsip terapi ini adalah memberikan antibodi para penyintas Covid 19 yang telah survive (sembuh). Terapi plasma Konvalesent mempercepat konversi positif ke negatif corona virus. Baca artikel selengkapnya

Imunoterapi

Belum ditemukannya obat yang secara efektif melawan covid 19 menjadikan obat-obatan peningkat imun menjadi alternatif dalam menjaga daya tahan tubuh. Salah satunya adalah obat bamlanivimab yang telah dipakai oleh mantan presiden Amerika Donal Trump.

Dokumen Pendukung untuk Covid 19 :

  1. Rekomendasi Surviving Sepsis Campaign untuk manajemen dan pengelolaan pasien sakit kritis dengan Covid 19, baca disini.
  2. Panduan informasi dan langkah pencegahan dan pengendalian coronavirus (COVID-19) di sekolah (UNICEF), unduh disini.
  3. Buku pegangan pencegahan dan penatalaksanaan covid 19 dari Alibaba Foundation, baca disini.
  4. Pedoman Pencegahan dan Pengendalian COVID-19 Kemenkes RI, unduh disinilah

Referensi

6609083 {6609083:9GG5D2UA},{6609083:PHIMXW4J},{6609083:DAGVX8HG},{6609083:RKCEDIGG},{6609083:9QS3BMXF},{6609083:8W8TAN3E},{6609083:V48WHKAW},{6609083:ST36SQBU},{6609083:MABD3IDA},{6609083:54CZICPX},{6609083:GBHHRZI5},{6609083:9U8ZFFWG},{6609083:54ESKK5P},{6609083:IEZMEFTR} 1 apa 50 default 572 https://deiari.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22IEZMEFTR%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bi%26gt%3BRNA%20Vaccines%20%28mRNA%20Vaccine%29%20-%20Basis%20of%20Pfizer%20and%20Moderna%20COVID-19%20vaccines%2C%20Animation%20-%20YouTube%26lt%3B%5C%2Fi%26gt%3B.%20%28n.d.%29.%20Retrieved%20January%2027%2C%202021%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.youtube.com%5C%2Fwatch%3Fv%3DoMXGGmBfkf8%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.youtube.com%5C%2Fwatch%3Fv%3DoMXGGmBfkf8%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22RNA%20Vaccines%20%28mRNA%20Vaccine%29%20-%20Basis%20of%20Pfizer%20and%20Moderna%20COVID-19%20vaccines%2C%20Animation%20-%20YouTube%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.youtube.com%5C%2Fwatch%3Fv%3DoMXGGmBfkf8%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-01-27T18%3A13%3A17Z%22%7D%7D%2C%7B%22key%22%3A%2254ESKK5P%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bi%26gt%3BCovid-19%20Vaccine%20Resource%20Center%26lt%3B%5C%2Fi%26gt%3B.%20%28n.d.%29.%20New%20England%20Journal%20of%20Medicine.%20Retrieved%20January%2027%2C%202021%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.nejm.org%5C%2Fcovid-vaccine%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.nejm.org%5C%2Fcovid-vaccine%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22Covid-19%20Vaccine%20Resource%20Center%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22The%20Covid-19%20vaccine%20resource%20center%20includes%20a%20collection%20of%20articles%2C%20FAQs%2C%20and%20related%20content%20to%20help%20educate%20and%20empower%20clinicians%20and%20their%20practice.%22%2C%22date%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nejm.org%5C%2Fcovid-vaccine%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-01-27T18%3A11%3A15Z%22%7D%7D%2C%7B%22key%22%3A%229U8ZFFWG%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bi%26gt%3BCOVID-19%20Vaccine%20Development%3A%20Behind%20the%20Scenes%26lt%3B%5C%2Fi%26gt%3B.%20%28n.d.%29.%20NIH%20COVID-19%20Research.%20Retrieved%20January%2018%2C%202021%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fcovid19.nih.gov%5C%2Fresearch-highlights%5C%2Fvaccine-development%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fcovid19.nih.gov%5C%2Fresearch-highlights%5C%2Fvaccine-development%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22COVID-19%20Vaccine%20Development%3A%20Behind%20the%20Scenes%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fcovid19.nih.gov%5C%2Fresearch-highlights%5C%2Fvaccine-development%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-01-18T04%3A16%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22GBHHRZI5%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shah%20et%20al.%22%2C%22parsedDate%22%3A%222020-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BShah%2C%20S.%2C%20Shah%2C%20K.%2C%20Patel%2C%20S.%20B.%2C%20Patel%2C%20F.%20S.%2C%20Osman%2C%20M.%2C%20Velagapudi%2C%20P.%2C%20Turagam%2C%20M.%20K.%2C%20Lakkireddy%2C%20D.%2C%20%26amp%3B%20Garg%2C%20J.%20%282020%29.%20Elevated%20d-Dimer%20Levels%20Are%20Associated%20With%20Increased%20Risk%20of%20Mortality%20in%20Coronavirus%20Disease%202019%3A%20A%20Systematic%20Review%20and%20Meta-Analysis.%20%26lt%3Bi%26gt%3BCardiology%20in%20Review%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B28%26lt%3B%5C%2Fi%26gt%3B%286%29%2C%20295%26%23x2013%3B302.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FCRD.0000000000000330%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FCRD.0000000000000330%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Elevated%20d-Dimer%20Levels%20Are%20Associated%20With%20Increased%20Risk%20of%20Mortality%20in%20Coronavirus%20Disease%202019%3A%20A%20Systematic%20Review%20and%20Meta-Analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siddharth%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kuldeep%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Siddharth%20B.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Foram%20S.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohammed%22%2C%22lastName%22%3A%22Osman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Poonam%22%2C%22lastName%22%3A%22Velagapudi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohit%20K.%22%2C%22lastName%22%3A%22Turagam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhanunjaya%22%2C%22lastName%22%3A%22Lakkireddy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jalaj%22%2C%22lastName%22%3A%22Garg%22%7D%5D%2C%22abstractNote%22%3A%22The%202019%20novel%20coronavirus%2C%20declared%20a%20pandemic%2C%20has%20infected%202.6%20million%20people%20as%20of%20April%2027%2C%202020%2C%20and%20has%20resulted%20in%20the%20death%20of%20181%2C938%20people.%20d-dimer%20is%20an%20important%20prognostic%20tool%2C%20is%20often%20elevated%20in%20patients%20with%20severe%20coronavirus%20disease-19%20%28COVID-19%29%20infection%20and%20in%20those%20who%20suffered%20death.%20In%20this%20systematic%20review%2C%20we%20aimed%20to%20investigate%20the%20prognostic%20role%20of%20d-dimer%20in%20COVID-19-infected%20patients.%20We%20searched%20PubMed%2C%20Medline%2C%20Embase%2C%20Ovid%2C%20and%20Cochrane%20for%20studies%20reporting%20admission%20d-dimer%20levels%20in%20COVID-19%20patients%20and%20its%20effect%20on%20mortality.%20Eighteen%20studies%20%2816%20retrospective%20and%202%20prospective%29%20with%20a%20total%20of%203682%20patients%20met%20the%20inclusion%20criteria.%20The%20pooled%20weighted%20mean%20difference%20%28WMD%29%20demonstrated%20significantly%20elevated%20d-dimer%20levels%20in%20patients%20who%20died%20versus%20those%20who%20survived%20%28WMD%2C%206.13%5Cu2009mg%5C%2FL%3B%2095%25%20confidence%20interval%20%5BCI%5D%204.16%5Cu20138.11%3B%20P%20%26lt%3B%200.001%29.%20Similarly%2C%20the%20pooled%20mean%20d-dimer%20levels%20were%20significantly%20elevated%20in%20patients%20with%20severe%20COVID-19%20infection%20%28WMD%2C%200.54%5Cu2009mg%5C%2FL%3B%2095%25%20CI%200.28%5Cu20130.80%3B%20P%20%26lt%3B%200.001%29.%20The%20risk%20of%20mortality%20was%20fourfold%20higher%20in%20patients%20with%20positive%20d-dimer%20versus%20negative%20d-dimer%20%28risk%20ratio%2C%204.11%3B%2095%25%20CI%2C%202.48%5Cu20136.84%3B%20P%20%26lt%3B%200.001%29%20and%20the%20risk%20of%20developing%20severe%20disease%20was%20twofold%20higher%20in%20patients%20with%20positive%20d-dimer%20levels%20versus%20negative%20d-dimer%20%28risk%20ratio%2C%202.04%3B%2095%25%20CI%2C%201.34%5Cu20133.11%3B%20P%20%26lt%3B%200.001%29.%20Our%20meta-analysis%20demonstrates%20that%20patients%20with%20COVID-19%20infection%20presenting%20with%20elevated%20d-dimer%20levels%20have%20an%20increased%20risk%20of%20severe%20disease%20and%20mortality.%22%2C%22date%22%3A%22November%5C%2FDecember%202020%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1097%5C%2FCRD.0000000000000330%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.lww.com%5C%2Fcardiologyinreview%5C%2FAbstract%5C%2F2020%5C%2F11000%5C%2FElevated_d_Dimer_Levels_Are_Associated_With.5.aspx%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221061-5377%22%2C%22language%22%3A%22en-US%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-01-08T07%3A08%3A50Z%22%7D%7D%2C%7B%22key%22%3A%2254CZICPX%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wang%20et%20al.%22%2C%22parsedDate%22%3A%222020-03-17%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BWang%2C%20D.%2C%20Hu%2C%20B.%2C%20Hu%2C%20C.%2C%20Zhu%2C%20F.%2C%20Liu%2C%20X.%2C%20Zhang%2C%20J.%2C%20Wang%2C%20B.%2C%20Xiang%2C%20H.%2C%20Cheng%2C%20Z.%2C%20Xiong%2C%20Y.%2C%20Zhao%2C%20Y.%2C%20Li%2C%20Y.%2C%20Wang%2C%20X.%2C%20%26amp%3B%20Peng%2C%20Z.%20%282020%29.%20Clinical%20Characteristics%20of%20138%20Hospitalized%20Patients%20With%202019%20Novel%20Coronavirus%26%23x2013%3BInfected%20Pneumonia%20in%20Wuhan%2C%20China.%20%26lt%3Bi%26gt%3BJAMA%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B323%26lt%3B%5C%2Fi%26gt%3B%2811%29%2C%201061.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Fjama.2020.1585%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1001%5C%2Fjama.2020.1585%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20Characteristics%20of%20138%20Hospitalized%20Patients%20With%202019%20Novel%20Coronavirus%5Cu2013Infected%20Pneumonia%20in%20Wuhan%2C%20China%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dawei%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bo%22%2C%22lastName%22%3A%22Hu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chang%22%2C%22lastName%22%3A%22Hu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fangfang%22%2C%22lastName%22%3A%22Zhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xing%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Binbin%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hui%22%2C%22lastName%22%3A%22Xiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhenshun%22%2C%22lastName%22%3A%22Cheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yong%22%2C%22lastName%22%3A%22Xiong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yan%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yirong%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xinghuan%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhiyong%22%2C%22lastName%22%3A%22Peng%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020-03-17%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1001%5C%2Fjama.2020.1585%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjamanetwork.com%5C%2Fjournals%5C%2Fjama%5C%2Ffullarticle%5C%2F2761044%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220098-7484%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-01-07T17%3A07%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22MABD3IDA%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zhang%20et%20al.%22%2C%22parsedDate%22%3A%222020-04-23%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BZhang%2C%20Y.%2C%20Xiao%2C%20M.%2C%20Zhang%2C%20S.%2C%20Xia%2C%20P.%2C%20Cao%2C%20W.%2C%20Jiang%2C%20W.%2C%20Chen%2C%20H.%2C%20Ding%2C%20X.%2C%20Zhao%2C%20H.%2C%20Zhang%2C%20H.%2C%20Wang%2C%20C.%2C%20Zhao%2C%20J.%2C%20Sun%2C%20X.%2C%20Tian%2C%20R.%2C%20Wu%2C%20W.%2C%20Wu%2C%20D.%2C%20Ma%2C%20J.%2C%20Chen%2C%20Y.%2C%20Zhang%2C%20D.%2C%20%26%23x2026%3B%20Zhang%2C%20S.%20%282020%29.%20Coagulopathy%20and%20Antiphospholipid%20Antibodies%20in%20Patients%20with%20Covid-19.%20%26lt%3Bi%26gt%3BNew%20England%20Journal%20of%20Medicine%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B382%26lt%3B%5C%2Fi%26gt%3B%2817%29%2C%20e38.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMc2007575%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMc2007575%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Coagulopathy%20and%20Antiphospholipid%20Antibodies%20in%20Patients%20with%20Covid-19%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yan%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meng%22%2C%22lastName%22%3A%22Xiao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shulan%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Xia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huan%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xin%22%2C%22lastName%22%3A%22Ding%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hua%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hongmin%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chunyao%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xuefeng%22%2C%22lastName%22%3A%22Sun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ran%22%2C%22lastName%22%3A%22Tian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dong%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jie%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dong%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiaowei%22%2C%22lastName%22%3A%22Yan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiang%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhengyin%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinglan%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bin%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yan%22%2C%22lastName%22%3A%22Qin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peng%22%2C%22lastName%22%3A%22Gao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xuzhen%22%2C%22lastName%22%3A%22Qin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yingchun%22%2C%22lastName%22%3A%22Xu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wen%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taisheng%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fengchun%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yongqiang%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yongzhe%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shuyang%22%2C%22lastName%22%3A%22Zhang%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020-04-23%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1056%5C%2FNEJMc2007575%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.nejm.org%5C%2Fdoi%5C%2F10.1056%5C%2FNEJMc2007575%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220028-4793%2C%201533-4406%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-01-07T16%3A33%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22ST36SQBU%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Berutu%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBerutu%2C%20S.%20A.%20%28n.d.%29.%20%26lt%3Bi%26gt%3BKemenhub%20Putuskan%20Tolak%20Usulan%20KRL%20Setop%20Beroperasi%20Saat%20PSBB%26lt%3B%5C%2Fi%26gt%3B.%20detiknews.%20Retrieved%20June%2019%2C%202020%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fnews.detik.com%5C%2Fberita%5C%2Fd-4981208%5C%2Fkemenhub-putuskan-tolak-usulan-krl-setop-beroperasi-saat-psbb%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fnews.detik.com%5C%2Fberita%5C%2Fd-4981208%5C%2Fkemenhub-putuskan-tolak-usulan-krl-setop-beroperasi-saat-psbb%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22Kemenhub%20Putuskan%20Tolak%20Usulan%20KRL%20Setop%20Beroperasi%20Saat%20PSBB%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sachril%20Agustin%22%2C%22lastName%22%3A%22Berutu%22%7D%5D%2C%22abstractNote%22%3A%22%26quot%3BKRL%20di%20Jabodetabek%2C%20selama%20ditetapkan%20PSBB%2C%20pengendalian%20yang%20dilakukan%20adalah%20dengan%20pembatasan%2C%20bukan%20menutup%20atau%20melarang%20sama%20sekali%2C%26quot%3B%20kata%20Zulfikri.%22%2C%22date%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fnews.detik.com%5C%2Fberita%5C%2Fd-4981208%5C%2Fkemenhub-putuskan-tolak-usulan-krl-setop-beroperasi-saat-psbb%22%2C%22language%22%3A%22id-ID%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-06-19T15%3A41%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22V48WHKAW%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Okezone%22%2C%22parsedDate%22%3A%222020-05-04%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BOkezone.%20%282020%2C%20May%204%29.%20%26lt%3Bi%26gt%3B3%20Penumpang%20KRL%20Bogor-Jakarta%20Positif%20Covid-19%26%23x202F%3B%3A%20Okezone%20Megapolitan%26lt%3B%5C%2Fi%26gt%3B.%20https%3A%5C%2F%5C%2Fmegapolitan.okezone.com%5C%2F.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fmegapolitan.okezone.com%5C%2Fread%5C%2F2020%5C%2F05%5C%2F04%5C%2F338%5C%2F2208642%5C%2F3-penumpang-krl-bogor-jakarta-positif-covid-19%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fmegapolitan.okezone.com%5C%2Fread%5C%2F2020%5C%2F05%5C%2F04%5C%2F338%5C%2F2208642%5C%2F3-penumpang-krl-bogor-jakarta-positif-covid-19%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%223%20Penumpang%20KRL%20Bogor-Jakarta%20Positif%20Covid-19%20%3A%20Okezone%20Megapolitan%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Okezone%22%7D%5D%2C%22abstractNote%22%3A%22Sebanyak%20tiga%20penumpang%20KRL%20Commuter%20Line%20yang%20menjalani%20swab%20test%20massal%20di%20Stasiun%20Bogor%20beberapa%20waktu%20dinyatakan%20positif%20covid19%20-%20Megapolitan%20-%20Okezone%20Megapolitan%22%2C%22date%22%3A%222020-05-04T05%3A19%3A58%2B07%3A00%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fmegapolitan.okezone.com%5C%2Fread%5C%2F2020%5C%2F05%5C%2F04%5C%2F338%5C%2F2208642%5C%2F3-penumpang-krl-bogor-jakarta-positif-covid-19%22%2C%22language%22%3A%22id-ID%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-06-19T15%3A39%3A15Z%22%7D%7D%2C%7B%22key%22%3A%229GG5D2UA%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bi%26gt%3BPenyakit%20koronavirus%202019%20-%20Wikipedia%20bahasa%20Indonesia%2C%20ensiklopedia%20bebas%26lt%3B%5C%2Fi%26gt%3B.%20%28n.d.%29.%20Retrieved%20June%2018%2C%202020%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fid.wikipedia.org%5C%2Fwiki%5C%2FPenyakit_koronavirus_2019%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fid.wikipedia.org%5C%2Fwiki%5C%2FPenyakit_koronavirus_2019%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22Penyakit%20koronavirus%202019%20-%20Wikipedia%20bahasa%20Indonesia%2C%20ensiklopedia%20bebas%22%2C%22creators%22%3A%5B%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fid.wikipedia.org%5C%2Fwiki%5C%2FPenyakit_koronavirus_2019%22%2C%22language%22%3A%22id%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-06-18T02%3A06%3A23Z%22%7D%7D%2C%7B%22key%22%3A%229QS3BMXF%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cao%20and%20Li%22%2C%22parsedDate%22%3A%222020-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCao%2C%20W.%2C%20%26amp%3B%20Li%2C%20T.%20%282020%29.%20COVID-19%3A%20towards%20understanding%20of%20pathogenesis.%20%26lt%3Bi%26gt%3BCell%20Research%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B30%26lt%3B%5C%2Fi%26gt%3B%285%29%2C%20367%26%23x2013%3B369.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41422-020-0327-4%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41422-020-0327-4%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22COVID-19%3A%20towards%20understanding%20of%20pathogenesis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taisheng%22%2C%22lastName%22%3A%22Li%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020-05%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41422-020-0327-4%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41422-020-0327-4%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221748-7838%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-06-18T02%3A05%3A07Z%22%7D%7D%2C%7B%22key%22%3A%228W8TAN3E%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sebayang%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSebayang%2C%20R.%20%28n.d.%29.%20%26lt%3Bi%26gt%3BAlert%21%20WHO%20Minta%20RI%20Setop%20Pakai%20Klorokuin%20untuk%20COVID-19%26lt%3B%5C%2Fi%26gt%3B.%20news.%20Retrieved%20June%2018%2C%202020%2C%20from%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.cnbcindonesia.com%5C%2Fnews%5C%2F20200527121142-4-161166%5C%2Falert-who-minta-ri-setop-pakai-klorokuin-untuk-covid-19%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.cnbcindonesia.com%5C%2Fnews%5C%2F20200527121142-4-161166%5C%2Falert-who-minta-ri-setop-pakai-klorokuin-untuk-covid-19%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22Alert%21%20WHO%20Minta%20RI%20Setop%20Pakai%20Klorokuin%20untuk%20COVID-19%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rehia%22%2C%22lastName%22%3A%22Sebayang%22%7D%5D%2C%22abstractNote%22%3A%22Organisasi%20Kesehatan%20Dunia%20%28WHO%29%20mendesak%20Indonesia%20untuk%20menangguhkan%20penggunaan%20obat%20malaria%20untuk%20mengobati%20pasien%20terinfeksi%20virus%20corona%20%28COVID-19%29.%22%2C%22date%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.cnbcindonesia.com%5C%2Fnews%5C%2F20200527121142-4-161166%5C%2Falert-who-minta-ri-setop-pakai-klorokuin-untuk-covid-19%22%2C%22language%22%3A%22id-ID%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-06-18T02%3A04%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22RKCEDIGG%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yazdany%20and%20Kim%22%2C%22parsedDate%22%3A%222020-03-31%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BYazdany%2C%20J.%2C%20%26amp%3B%20Kim%2C%20A.%20H.%20J.%20%282020%29.%20Use%20of%20Hydroxychloroquine%20and%20Chloroquine%20During%20the%20COVID-19%20Pandemic%3A%20What%20Every%20Clinician%20Should%20Know.%20%26lt%3Bi%26gt%3BAnnals%20of%20Internal%20Medicine%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B172%26lt%3B%5C%2Fi%26gt%3B%2811%29%2C%20754%26%23x2013%3B755.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7326%5C%2FM20-1334%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7326%5C%2FM20-1334%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Use%20of%20Hydroxychloroquine%20and%20Chloroquine%20During%20the%20COVID-19%20Pandemic%3A%20What%20Every%20Clinician%20Should%20Know%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinoos%22%2C%22lastName%22%3A%22Yazdany%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alfred%20H.J.%22%2C%22lastName%22%3A%22Kim%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22March%2031%2C%202020%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.7326%5C%2FM20-1334%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.acpjournals.org%5C%2Fdoi%5C%2F10.7326%5C%2FM20-1334%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220003-4819%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-06-18T02%3A04%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22DAGVX8HG%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cahyani%22%2C%22parsedDate%22%3A%222020-03-23%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCahyani%2C%20D.%20R.%20%282020%2C%20March%2023%29.%20%26lt%3Bi%26gt%3BCorona%2C%20Jokowi%20Klaim%20RI%20Punya%20Stok%203%20Juta%20Chloroquine%26lt%3B%5C%2Fi%26gt%3B.%20Tempo.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fbisnis.tempo.co%5C%2Fread%5C%2F1322849%5C%2Fcorona-jokowi-klaim-ri-punya-stok-3-juta-chloroquine%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fbisnis.tempo.co%5C%2Fread%5C%2F1322849%5C%2Fcorona-jokowi-klaim-ri-punya-stok-3-juta-chloroquine%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22webpage%22%2C%22title%22%3A%22Corona%2C%20Jokowi%20Klaim%20RI%20Punya%20Stok%203%20Juta%20Chloroquine%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dewi%20Rina%22%2C%22lastName%22%3A%22Cahyani%22%7D%5D%2C%22abstractNote%22%3A%22Presiden%20Jokowi%20menyatakan%20RI%20memiliki%20stok%20chloroquine%20yang%20diyakin%20dapat%20membuat%20pasien%20virus%20corona%20membaik.%22%2C%22date%22%3A%222020-03-23T10%3A49%3A18%2B07%3A00%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fbisnis.tempo.co%5C%2Fread%5C%2F1322849%5C%2Fcorona-jokowi-klaim-ri-punya-stok-3-juta-chloroquine%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-06-18T02%3A02%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22PHIMXW4J%22%2C%22library%22%3A%7B%22id%22%3A6609083%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Dong%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDong%2C%20E.%2C%20Du%2C%20H.%2C%20%26amp%3B%20Gardner%2C%20L.%20%282020%29.%20An%20interactive%20web-based%20dashboard%20to%20track%20COVID-19%20in%20real%20time.%20%26lt%3Bi%26gt%3BThe%20Lancet.%20Infectious%20Diseases%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B20%26lt%3B%5C%2Fi%26gt%3B%285%29%2C%20533%26%23x2013%3B534.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2820%2930120-1%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2820%2930120-1%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20interactive%20web-based%20dashboard%20to%20track%20COVID-19%20in%20real%20time%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ensheng%22%2C%22lastName%22%3A%22Dong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hongru%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lauren%22%2C%22lastName%22%3A%22Gardner%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2205%202020%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2FS1473-3099%2820%2930120-1%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%2232087114%22%2C%22PMCID%22%3A%22PMC7159018%22%2C%22ISSN%22%3A%221474-4457%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-06-18T02%3A02%3A01Z%22%7D%7D%5D%7D
RNA Vaccines (mRNA Vaccine) - Basis of Pfizer and Moderna COVID-19 vaccines, Animation - YouTube. (n.d.). Retrieved January 27, 2021, from https://www.youtube.com/watch?v=oMXGGmBfkf8
Covid-19 Vaccine Resource Center. (n.d.). New England Journal of Medicine. Retrieved January 27, 2021, from https://www.nejm.org/covid-vaccine
COVID-19 Vaccine Development: Behind the Scenes. (n.d.). NIH COVID-19 Research. Retrieved January 18, 2021, from https://covid19.nih.gov/research-highlights/vaccine-development
Shah, S., Shah, K., Patel, S. B., Patel, F. S., Osman, M., Velagapudi, P., Turagam, M. K., Lakkireddy, D., & Garg, J. (2020). Elevated d-Dimer Levels Are Associated With Increased Risk of Mortality in Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Cardiology in Review, 28(6), 295–302. https://doi.org/10.1097/CRD.0000000000000330
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., & Peng, Z. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA, 323(11), 1061. https://doi.org/10.1001/jama.2020.1585
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., Wang, C., Zhao, J., Sun, X., Tian, R., Wu, W., Wu, D., Ma, J., Chen, Y., Zhang, D., … Zhang, S. (2020). Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. New England Journal of Medicine, 382(17), e38. https://doi.org/10.1056/NEJMc2007575
Berutu, S. A. (n.d.). Kemenhub Putuskan Tolak Usulan KRL Setop Beroperasi Saat PSBB. detiknews. Retrieved June 19, 2020, from https://news.detik.com/berita/d-4981208/kemenhub-putuskan-tolak-usulan-krl-setop-beroperasi-saat-psbb
Okezone. (2020, May 4). 3 Penumpang KRL Bogor-Jakarta Positif Covid-19 : Okezone Megapolitan. https://megapolitan.okezone.com/. https://megapolitan.okezone.com/read/2020/05/04/338/2208642/3-penumpang-krl-bogor-jakarta-positif-covid-19
Penyakit koronavirus 2019 - Wikipedia bahasa Indonesia, ensiklopedia bebas. (n.d.). Retrieved June 18, 2020, from https://id.wikipedia.org/wiki/Penyakit_koronavirus_2019
Cao, W., & Li, T. (2020). COVID-19: towards understanding of pathogenesis. Cell Research, 30(5), 367–369. https://doi.org/10.1038/s41422-020-0327-4
Sebayang, R. (n.d.). Alert! WHO Minta RI Setop Pakai Klorokuin untuk COVID-19. news. Retrieved June 18, 2020, from https://www.cnbcindonesia.com/news/20200527121142-4-161166/alert-who-minta-ri-setop-pakai-klorokuin-untuk-covid-19
Yazdany, J., & Kim, A. H. J. (2020). Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know. Annals of Internal Medicine, 172(11), 754–755. https://doi.org/10.7326/M20-1334
Cahyani, D. R. (2020, March 23). Corona, Jokowi Klaim RI Punya Stok 3 Juta Chloroquine. Tempo. https://bisnis.tempo.co/read/1322849/corona-jokowi-klaim-ri-punya-stok-3-juta-chloroquine
Dong, E., Du, H., & Gardner, L. (2020). An interactive web-based dashboard to track COVID-19 in real time. The Lancet. Infectious Diseases, 20(5), 533–534. https://doi.org/10.1016/S1473-3099(20)30120-1


Ns. Ari Wahyuningsih,S.Kep

Perawat di RS dr. Suyoto Kemhan

0 Comments

Tinggalkan Balasan

Avatar placeholder

Alamat email Anda tidak akan dipublikasikan. Ruas yang wajib ditandai *

error: Content is protected !!